Radius Health
About:
Radius Health develops drug therapies for osteoporosis and women’s health.
Website: http://www.radiuspharm.com
Twitter/X: radius_health
Top Investors: Wellcome Trust, Nordic Bioscience, MPM Capital, Oxford Bioscience Partners, HealthCare Ventures
Description:
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging. Radius's scientific leadership includes some of the world's leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.
$1.03B
$100M to $500M
Cambridge, Massachusetts, United States
2003-11-01
info(AT)radiuspharm.com
John A. Katzenellenbogen, John Potts, Michael Rosenblatt, Stavros C. Manolagas
251-500
2021-03-03
Public
© 2025 bioDAO.ai